
Pharmacy Times® interviewed Clayton Edwards, RPh, MBA, chief operating officer of AllianceRx Walgreens Prime, on the importance of disaster preparation in pharmacies during hurricane season in the midst of a pandemic.
Pharmacy Times® interviewed Clayton Edwards, RPh, MBA, chief operating officer of AllianceRx Walgreens Prime, on the importance of disaster preparation in pharmacies during hurricane season in the midst of a pandemic.
Fiona Zhou, PharmD candidate at University of the Sciences, Philadelphia College of Pharmacy, shares her thoughts on the value of pharmacy and the role of pharmacists in health care.
Pharmacy Times® interviewed Clayton Edwards, the Chief Operating Officer of AllianceRx Walgreen Prime, on the value of a specialty pharmacist in the management of patient care.
Pharmacy Times spoke with Jessica Langley, MS, executive director of education and advocacy of NHA, about how the pandemic has changed the pharmacy technician industry and advice for future pharmacy technician opportunities.
Although transfering the annual event to a virtual format presented challenges, NASP President and CEO Sheila Arquette, RPh, said she is excited to connect with attendees just as much as in previous years.
This Pharmacy Times® Webcast discusses a number of topics pertaining to the pharmacists’ role in immunization practices, including the precautions and safety equipment necessary amidst the COVID-19 pandemic, pharmacy automation and operations, and best practices to navigate patient care.
As accessible health care providers, pharmacists are in a great position to spread much-needed information.
Moss will soon begin offering weekly social media tips and tricks in live events on the Pharmacy Times Facebook and Instagram pages, with topics such as finding your niche, creating content, and planning ahead on social media platforms.
Pharmacy Times spoke with Ron Lanton, Principal at Lanton Law, about Rutledge v. PCMA and its impact on pharmacy and PBMs.
This Pharmacy Times Webcast provides an overview of how the COVID-19 pandemic has impacted the treatment and management of patients with cancer.
Congress is in the middle of discussing this issue, Hogue said, meaning pharmacists need to advocate for provider status immediately.